In contrast, Cxcr2-/- mixed BM chimeras exhibit patient-like features, including circulating neutropenia and BM myelokathexis (13), but present challenges like immune interactions, donor cell variability, and complications from conditioning regimens and immunosuppression (53, 54). Here, CXCR2 is linked to neutropenia.